AXTI Stock Rips As AI Demand Fuels Profit Turnaround

AXT Inc stocks have been trading up by 8.92 percent following upbeat semiconductor demand news boosting investor optimism.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading AXTI

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Q1 revenue for AXTI climbed to $26.9M from $19.4M a year earlier, with an adjusted loss narrowed to $0.01 per share, yet the stock still slipped about 5.5% after hours.
For Q2, AXTI now targets EPS of $0.06–$0.08 instead of a loss, backed by record indium phosphide demand and a backlog above $100M tied to AI and data center upgrades.
The company raised roughly $632.5M in gross proceeds at $64.25 per share through an underwritten offering, aimed at ramping indium phosphide capacity and R&D at its Beijing Tongmei unit.
Wedbush has hiked its AXTI price target twice, now at $93 with an Outperform rating, while Northland and B. Riley also raised targets, signaling a broad bullish reset on the name.
A new 2x long single‑stock ETF (AXTX) tracking AXTI spotlights the stock within AI and data‑infrastructure themes and may boost liquidity and day‑trading interest.

Live Update At 14:04:28 EDT: On Friday, May 15, 2026 AXT Inc stock [NASDAQ: AXTI] is trending up by 8.92%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

AXTI is trading like a classic high‑beta AI infrastructure play. The daily chart shows a powerful trend: from a close of $78.76 on 2026/04/20 to $125.24 on 2026/05/15, the stock has surged more than 50% in under a month. Volatility is intense, with swings from $110.11 intraday lows to $134 highs over recent sessions.

Under the hood, AXTI is still cleaning up its income statement. The latest quarter shows revenue of $26.9M and a small net loss of about $1.5M, but margins are moving in the right direction. Adjusted loss per share has tightened to $0.01, and Q2 guidance points to positive EPS.

More Breaking News

Key ratios remind traders this is a richly valued growth story. AXTI’s price‑to‑sales near 76.7 and price‑to‑book above 25 imply a heavy premium for future growth, not current profits. At the same time, the balance sheet looks solid, with a current ratio of 2.7 and low leverage. For active traders, that combo—strong trend, high valuation, improving but negative GAAP earnings—spells momentum with real downside risk if the story stumbles.

Why Traders Are Watching AXTI Now

AXTI has quickly moved from a sleepy materials name to a front‑line AI infrastructure trade. The catalyst was a series of upside surprises and aggressive guidance. Q1 numbers came in slightly ahead on revenue and much better on adjusted EPS, shrinking the adjusted loss to $0.01 per share with sales jumping to $26.9M from $19.4M. That’s not story stock fluff; that is real operational progress.

Then AXTI put out Q2 guidance that grabbed Wall Street’s attention. Management now expects EPS of $0.06–$0.08 when many on the Street were looking for a small loss. The company pointed to sequential revenue growth, record demand for indium phosphide, and a backlog above $100M tied to AI and data‑center upgrades. That kind of visibility is rare in this market, even if export‑permit timing injects some execution noise.

To chase this demand, AXTI went big on capital. The company priced and completed an underwritten common‑stock offering at $64.25 per share, ultimately raising about $632.5M in gross proceeds, including the over‑allotment. The cash is earmarked for expanding indium phosphide substrate capacity at its Beijing Tongmei subsidiary, plus R&D and general corporate uses. Traders hated the dilution near term—AXTI sold off 7.3% after the announcement and over 12% on pricing—but structurally, it funds the next leg of growth.

Layer on sentiment. Wedbush ratcheted its AXTI target from $28 to $80, then to $93, each time with an Outperform rating and commentary focused on margin improvement and upside in the back half of the year. Northland doubled its target to $90 with an Outperform call, while B. Riley jumped from $21 to $72 and later to $73, even while staying Neutral. That spread tells traders two things: the Street is broadly bullish on AXTI’s AI and optical‑connectivity angle, and expectations are now very high.

Finally, Tradr’s launch of a 2x long single‑stock ETF, AXTX, tied directly to AXTI, adds gasoline to the fire. A leveraged vehicle like AXTX often drives more volume and sharper intraday swings, turning AXTI into a favorite battlefield for momentum and short‑term tactical trading.

Conclusion

For active traders, AXTI is a textbook momentum story wrapped around a real secular trend. The company is leaning into AI data‑center demand with indium phosphide substrates, backing its vision with a sizeable $632.5M capital raise and a ramp plan at Beijing Tongmei. Q1 execution has already improved, and Q2 guidance flips the script from losses to expected profitability, with a backlog north of $100M hinting at sustained demand.

But none of this is a free lunch. AXTI’s valuation is stretched, profitability is still young, and dilution from the equity raise remains an overhang as new shares work through the market. Analyst targets in the $72–$93 range show confidence, yet B. Riley’s Neutral stance is a reminder that not every desk is comfortable chasing AXTI at current levels.

For short‑term traders, the daily and intraday charts tell the story: strong trend, wide ranges, and clear levels where momentum accelerates or fails. The presence of the 2x AXTX ETF only amplifies that action. As Tim Sykes likes to hammer home, “It’s not about being right, it’s about trading with a plan and cutting losses quickly.” In the same spirit of process‑driven trading, As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.”. With AXTI, the opportunity is real—but so is the need for tight risk management and disciplined execution.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!